Patient Characteristics and Response Rates

Consecutive Patients (n = 10)
SexMale = 7, Female = 3
Median Age (range)70 (52–82)
Follow-up Time4.5–13.6 Months
ECOG Performance Score0 = 5, 1 = 4, 2 = 1
Patients with Distant Metastases2
Unresectale Stage III8
Stage IV2
Prior exposure to immunotherapy(1 adjuvant therapy, 2 systemic therapies)
Prior exposure to targeted therapy1
Overall Response Rate (On-target lesions)9/10
Overall Response Rate(Off-target lesions)2/2